By applying these measures, healthcare professionals can significantly reduce the risk of drug resistance in TB patients on an outpatient basis. The key to preventing drug resistance is to follow a treatment regimen, monitor progress, and make adjustments if necessary to treat complications or drug resistance. These actions should be part of a coordinated, patient-centered approach to TB treatment.

Human immunodeficiency virus, World Health Organization, medical and labor expert commission, preschool institutions, metered-dose inhaler, children's educational institutions.

Barkanova O.N., Kaluzhenina A.A., Popkova N.L., Gagarina S.G. Some problems of drug-resistant pulmonary tuberculosis // Conference dedicated to the 80th anniversary of VolgSMU. - September 2015.

Barkanova O.N., Kaluzhenina A.A., Popkova N.L., Gagarina S.G. Tuberculosis of the lungs with a multidrug-resistant pathogen // Notes of a scientist. December 2015. pp. 19-21.

Mistrikova N. G. Drug-resistant pulmonary tuberculosis // Young scientist. 2019. No. 47. pp. 171-173.

Nechaeva O.B., Skachkova E.I. The causes of the formation of multidrug resistance of Mycobacterium tuberculosis in the Sverdlovsk region // Healthcare TF. - 2003. - No. 3. - pp.33-35.

Sadirova D.S., Trubnikov A. B., Mukhtarov D. Z. - Causes and effectiveness of treatment of widespread drug resistance in patients with pulmonary tuberculosis//Young Scientist No. 5 (139) February 2017

Tillyashaykhov M.N. and co-authors. National guidelines for the program management of drug-resistant tuberculosis in the Republic of Uzbekistan. 2014. P.108.

Punga V.V., Rusakova L.I., Puzanov V.A. et al. Prevalence of drug-resistant tuberculosis // Tuberculosis and lung diseases. - 2011. — No. 10. — pp. 6-15.

Pritchard A.J., Hayward A.S., Monk P.N., Neal K.R. Risk factors for drug-resistant tuberculosis in Leicestershire - poor adherence to treatment remains an important cause of resistance // Epidemiol. And so on. - 2003. - Volume 130, No. 3. - pp.481-483.